Policy Briefs
New policy brief on ethical, legal and social aspects published
The Sino-EU PerMed project published its 2nd policy brief on ethical, legal and social aspects in the cooperation between Europe and China in Personalised Medicine. The policy brief is the result of the expertise by the ELSA Task Force that founded the project in 2023. It is also based on a workshop and a delegation visit to China where discussions were held with other experts on this topic. The insights gained from these activities are to be seen as recommendations for both policy and science.
The document addresses three topics: 1.) Why is ELSA important for development and implementation of PM? 2.) Legal and regulatory aspects: the health data perspective, and 3.) Ethical and societal perspectives.
More...
Link to ELSA Policy Brief
Delegations
Sino-EU PerMed Mission to China on ethical, legal and social aspects in Personalised Medicine
A delegation of experts in the field of ethical, legal, and social aspects in Personalised Medicine, alongside five project partners from the Sino-EU PerMed consortium, recently concluded a successful visit to China in April 2024. The visit, organised by DLR-PT in collaboration with Innovation Center Denmark, was a fact-finding mission focused on ELSA in the field of Personalised Medicine.
During their visit, the delegation had the opportunity to explore renowned Personalised Medicine research organisations, companies, and hospitals in Beijing, Guangzhou, and Shenzhen. Institutions visited included the Ethics Committee at Peking University, BeiGene, Novo Nordisk, Guangzhou Institutes for Biomedicine and Health, Sun Yat-sen University, Cancer Hospital, Hong Kong University Shenzhen Hospital, and BGI. The European experts who participated in the delegation came from Denmark, Germany, Great Britain, France, and Germany.
More...
Workshops
Sino-EU PerMed Workshop in Guangzhou on ethical, legal and social aspects in Personalised Medicine
The Sino-EU PerMed project recently held its final workshop in Guangzhou, China on 18 April 2024. This workshop focused on exploring the ethical, legal, and social aspects of Personalised Medicine in the collaboration between Europe and China. Experts from both regions came together to share their insights on this interdisciplinary topic. Throughout the workshop, examples from China and Europe were presented and discussed in relation to ethical, legal, and societal considerations. The event featured keynote and impulse talks, as well as in-depth discussions.
More...
Online
Sino-EU Permed Database
The Sino-EU PerMed Database is now accessible online, providing a vital resource for researchers and stakeholders involved in Personalised Medicine in China and Europe. This database serves as a comprehensive repository of information on patents and publications. Offering an extensive collection of data, it enables users to stay up-to-date with the latest developments and trends. Furthermore, after two years since the previous mapping, the report has been recently updated. This update means an enhanced and more accurate representation of the landscape of Personalised Medicine in both regions.
More...
|
